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ΑΞΙΟΛΟΓΗΣΗ ΣΤΗΝ ΠΡΑΞΗ ΤΗΣ ΕΝΕΣΙΜΗΣ ΑΠΡΑΜΥΚΙΝΗΣ ΓΙΑ 
ΤΟΝ ΕΛΕΓΧΟ ΤΗΣ ΚΟΛΟΒΑΚΤΗΡΙΔΙΑΣΕΩΣ ΤΩΝ ΜΟΣΧΑΡΙΩΝ 
Σ. ΚΥΡΙΑΚΗ*, Κ. ΣΑΡΡΗ**, Ι. ΑΝΔΡΕΩΤΗ*, Κ. ΤΣΑΛΤΑ* 
IN FIELD EVALUATION OF INJECTABLE APPRAMYCIN FOR THE CONTROL OF 
NATURALLY OCCURING COLIBACILLUS« 
IN YOUNG CALVES 
S. KYRIAKIS*, K. SARRIS**. J.S. ANDREOTIS*. C. TSALTAS* 
S U M M A R Y 
The efficacy of apramycin at 20mg/kg of body weight IM for 5 days was evaluated for the 
control of naturally oecuring colibacillosis in young calves (n,=20). Positive control calves 
(n ,=20) were treated with trimethoprim sulphadiazine and when symptoms persisted or recurred 
with Oxytetracycline and/or chloramphenicol IM at dosages and for periods recommented by the 
manufacturers. 
Scored clinical observations and diarrhoea were generally comparable between the two trea-
ment groups. Due to persistence or recurence of diarrhoea, positive control calves required a to­
tal of 160 IM injections as compared to 100 IM injections for apramycin group. The average 
daily gain of the apramycin calves was greater, although not significant (P 0.05), for the periods 
0-7 days and 7-14 days by 123.33% and 23.51% respectively. The overall improvement (0-14 
days) was statistically significant (Ρ 0.05) amounting to 44.6% over the controls. Mean serum 
immunoglobulin levels did not differ significantly (P 0.05) between the two treatment groups. 
From fecal swabs taken from all calves on trial days 0 and 5, E. colt was isolated and 9 strains 
were recognised enteropathogenic belonging to 4 serotypes. 
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INTRODUCTION 
Diarrohoea in newborn calves is a major cause of economic loss particular-
ly where intensified calf production is practiced. The aetiology of calf diarrhoea 
is unclear and although E. coli has been accepted as the primary pathogen, the 
interplay between enteropathogenic E. coli, rotavirus, corona virus, Salmonella 
spp and several epidemiological factors such as immunity of calves, overcro-
wding and other stresses make the disease a complex syndrome (Blood, Hen-
derson and Radostits, 1980). 
Fluid therapy and antibacterials are given orally and/or parenterally for the 
treatment of colibacillosis. 
The use of apramycin, an aminocyclitol antibiotic produced by a strain of 
Streptomyces tenebrarius, with a strong gram negative antibacterial activity 
including E. coli and Salmonella, (Wick and Welles, 1968, Ryden and Moore, 
1977) has been evaluated as a treatment for naturally occuring enteritis and 
pneumoenteritis in young calves (Pankhurst et al. 1975; Stoforos et al. 1978). 
The aim of this experiment was to evaluate the effectiveness of apramycin 
in comparison to a conventional treatment scheme used for the control of coli-
bacillosis in young calves. 
MATERIALS AND METHODS 
This experiment was carried out at a commercial weaning-finishing farm 
where 300, 10 day old Holstein-Friesian male calves were shipped by air from 
Canada to Athens and then transported by trucks to the farm. Previous expe-
rience with similarly transported animals resulted in a significant occurence of 
colibacillosis, usually within 2 to 3 days after arrival. Of these calves and 2 
days after they were settled, 40 with symptoms of diarrhoea were selected out, 
identified by ear tags and weighed. They were then randomly alloted to 2 
groups of 20 animals each and assigned to apramycin treatment and positive 
controls, respectively. 
The calves were confined individually in pens in a row within an environ-
mentally controled house. The mean weitht of the calves on trial day 0 was 
about 46 kg. 
A commercially available, non-medicated milk replacer was bucketfed to 
calves twice a day. Hay and a grain based ration supplemented with fish meal, 
vitamins and minerals was provided ad libitum. 
Apramycin, (Apralan Elanco) at a dose of 20 mg/kg was administered IM 
once daily for the first 5 days (trial days 0 to 5). Positive control animals were 
initally treated with trimethoprim-sulphadiazine (Tribrissen, 48% Inj., Wellco-
me) at 1 ml/30Kg IM for the first 5 days. In case the symptoms did not reso-
lve or recurred, treatment was repeated by using Oxytetracycline (Terramycin -
100 Inj., Pfizer) at 5 mg/kg IM for 5 days or chloramphenicol (Certaphenicol 
25% Certa) at 50 mg/10 kg for 4 days. Supportive therapy, when required, 
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was common to all animals regardless of treatment and consisted of solutions 
of electrolytes (Duphalyte, Duphar) at 6 ml/kg, administered IV. 
Temperatures and clinical observations including attitude, body condition, 
dehydration, appetite, respiratory rate, cough, nasal discharge and diarrhoea 
were recorded daily up to trial day 14. Numerical values from 0 (normal) to 3 
(fairly abnormal) given and clinical observation comprised the data base for cli-
nical evaluation. 
On days 0 and 5 fecal swabs were taken from all animals in an attempt to 
isolate E. coli and Samonellae. Conventional bacterial isolation methods were 
followed for these microbs. E. coli isolates were serotyped using the scheme of 
Sojka (1973). 
On day 0. immunoglobulin concentrations were measured on the sera of all 
calves by the ZST test ( \ ,cEwan et al., 1970). 
All calves were again weighed on trial days 7 and 14 and the «student's t 
test» was used for statistical analysis of average daily gain. 
RESULTS 
No mortality was observed throughout the trial period. The general sick-
ness score in both treatment groups was generally low (Fig. 1). A slight increa-
; 
MEAN GENERAL SICKNESS SCORE 
APRAMYCIN _ - _ _ POSITIVE CONTROLS 
TEMPERATURE 
FIGURE 1 
Mean general sickness scores and temperature diagramme of the apramycin and positive control 
groups. 
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se observed early during the second week accompanied by an elevation in tem-
peratures, as seen in Fig. 1, was caused mainly by respiratory symptoms. Diar-
rhoea which was present at the onset of the trial reduced constantly and was 
minimal at the end of the trial in both groups (Fig. 2). 
3 .0 
APRA.MYCIN 
POSITIVE CONTROLS 
T R I A L D A Y S 
FIGUR» 2. 
Mean daily diarrhoea scores of both treatment groups. 
Positive control animals were initially treated with trimethoprime-
sulphadiazine on trial days 0 to 5. Immediately following the 5 — day trea-
tment period, eight of the calves required an additional treatment with Oxytetra-
cycline due to persistence of symptoms and in 5 of these, treatment was again 
repeated by using chlorampenicol for the same reasons. As a consequence, the 
treatment period for these 5 animals was from day 0 up to day 13 of the trial. 
Therefore, an extra 60 doses of antibiotic were used in the postive control ca-
lves since both groups initially were given 100 injections. Electrolyte (Duphaly-
te) supportive therapy was given to 12 apramycin treated calves on trial days 1 
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and 2; to 10 positive control calves on days 1 and 2; to 6 calves upon initia­
tion of the Oxytetracycline treatment for 2 consecutive days (trial days 5 and 
6) and repeated again in 5 of these on trial days 10 and 11. 
Performance data are summarized in Table 1. As compared to the positive 
controls, the average daily gain (ADG) of the calves that had been treated with 
apramycin was better-though not significant - by 123. 3 3 % and 23.51% for the 
periods 0-7 days and 7-14 days, respectively. The overall improvement in 
ADG was, however, significant amounting to 44.6%. 
E. coli was isolated from all animals of both groups from fecal swabs taken 
on days 0 and 5. From these isolates 9 strains were recognised enteropathoge-
nic belonging to groups 0149:K91, K88ac; OV17: Κ «V17»; 064: Κ «V142» 
and 08: Κ «Ρ 16» (table 2). 
TABLE 1 
Summary of growth performance data of the apramycin and positive control 
groups. 
Parameter 
Initial weight (kg) 
Final weight 
ADG (g) 
ADG (g) 
ADG (g) 
Period 
(days) 
0 
14 
0 7 
7-14 
0-14 
Treatment 
Positive Control 
46.3a 
49.3a 
90a 
336a 
2l3 a 
means 
Apramycin 
46.7a 
51.0a 
20 l a 
415a 
308b 
Change (%) 
123.33 
23.51 
44.60 
Means in a row with different superscript letters differ significantly (P<0.05). 
TABLE 2 
Identified serotypes of E. coli isolates from fecal swabs taken on trial days 0 
and 5 
APRAMYCIN TREATED POSITIVE CONTROLS 
DAY 0 
SEROTYPE 
DAY 5 
No of SEROTYPE 
calves 
DAY 0 
No of SEROTYPE 
calves 
DAY 5 
No of SEROTYPE 
calves 
No of 
calves 
0149:K9I.K88 ac 
OV17:K «VI7» 
064:K «VI42» 
3 08:K«P16» 
1 064:K «V142» 
OV17:K «V17» 08:K «P16» 
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The mean serum immunoglobulin concentration expressed as ZST units 
was 12.3 (range 13.3) for the apramycin treated group and 11.9 (range 16.3) 
for the positive controls. The difference between the two treatment groups was 
not statistically significant (P > 0.05). 
DISCUSSION 
The results of this study, where we had a typical field infection of colibacil-
losis in calves with isolation of pathogenic E. coli strains, confirms previous re­
ports (Pankhurst et al, 1975; Stoforos et al. 1978). The clinical response in 
both groups of animals was similar. The ADG in the apramycin group was 
numerically superior for both weeks of trial and significantly improved overall. 
Both groups had similar mean immunoglobulin levels. Although an extra 
60 doses of antibiotic were used in the positive control calves no further anti­
biotic therapy was necessary in the apramycin group. 
Apramycin IM at 20 mg/kg once daily for 5 days has both clinical and 
practical advantages over alternative treatments commonly used in Greece for 
coliform diarrhoea in calves. 
ΠΕΡΙΛΗΨΗ 
'Έγινε αξιολόγηση της αποτελεσματικότητας της άπραμυκίνης στή δόση 
των 20mg/kg ζ.β., ενδομυϊκά, έπί 5 ήμερες, για τον έλεγχο της κολοβακτηρι-
διάσεως σέ 20 μικρά μοσχάρια ηλικίας 12-13 ημερών περίπου. Χρησιμοποιή 
θηκε Ίδιος αριθμός μαρτύρων των οποίων ή θεραπευτική αγωγή περιλάμβανα 
αρχικά χορήγηση trimethoprim-sulphadiazine καί στή συνέχεια, δταν τα συμ­
πτώματα δέν υποχωρούσαν ή επανεμφανίζονταν, οξυτετρακυκλίνη ή και χλω-
ραμφενικόλη. Ή χορήγηση των αντιβιοτικών αυτών γίνονταν ενδομυϊκά, σέ 
δόσεις και διάρκεια θεραπείας πού συνιστούσαν ol παρασκευαστές οίκοι. 
Οί διαβαθμίσεις των κλινικών συμπτωμάτων καί της διάρροιας ήτο\' παρό­
μοιες στις δύο θεραπευτικές ομάδες. Ή διάρκεια δμως ή καί ή έπανεμ 'νιση 
τής διάρροιας στους μάρτυρες έκανε απαραίτητη τήν επιπρόσθετη χορι, ^η 
60 δόσεων αντιβιοτικών· ώστε, ό συνολικός αριθμός των ενδομυϊκών ενέσεων 
νά φθάσει τους 160, σέ σύγκριση μέ τους 100 τής ομάδας τής άπραμυκίνης. 
Ή Μέση 'Ημερήσια Αύξηση Βάρους (ΜΗΑΒ) τών μοσχαριών τής ομάδας 
τής άπραμυκίνης ήταν αριθμητικά μεγαλύτερη — δχι δμως στατιστικά σημαν­
τική (Ρ>0.05) — σέ σύγκριση μέ τους μάρτυρες, κατά 123.33% γιά τή περίοδο 
0-7 ήμερες καί 23.51% γιά τή περίοδο 7-14 ήμερες. Ή συνολική (0-14 ήμε­
ρες) δμως βελτίωση τής ΜΗΑΒ ήταν στατιστικά σημαντική (Ρ<0.05) καί κα­
τά 44.6% μεγαλύτερη άπό αυτή τών μαρτύρων. Οί διαφορές τών μέσων τιμών 
τών συγκεντρώσεων τών άνοσοσφαιρινών στον ορό τών μόσχων τών δύο θε­
ραπευτικών ομάδων δέν ήταν στατιστικά σημαντικές (Ρ>0.05). Στελέχη Ε. 
coli απομονώθηκαν άπό τα κόπρανα δλων τών ζώων τις ήμερες 0 καί 5 του 
πειραματισμού. 'Από τήν ορολογική ταυτοποίηση πού επακολούθησε, 9 άπό 
αυτά τά στελέχη άνηκαν σέ 4 έντεροπαθογόνες ορολογικές ομάδες. 
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